High Stakes: Nvidia and Amazon Lead with Massive Trading Volumes
Tuesday, Nov 26, 2024 11:23 pm ET
2min read 1. Nvidia (Nasdaq: NVDA)
Nvidia gained mildly by 0.66%, with the trading volume of 25.84B. NVIDIA is set to release the new RTX 5090D graphics card, which will likely have reduced specifications but align closely with the RTX 5090 in hardware and performance.
2. Tesla (Nasdaq: TSLA)
Tesla dipped mildly by -0.11%, with the trading volume of 20.95B. Tesla's Texas plant may discharge toxic wastewater; UBS warns Tesla's valuation is driven by market sentiment, not fundamentals; Tesla cuts Model Y price by $10,000; Tesla recruits AI remote operation team; California's EV subsidies may exclude Tesla.
3. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated plunged by -12.33%, with the trading volume of 17.50B. MicroStrategy disclosed five insider transactions on November 25 and recently acquired approximately 55,500 bitcoins for about $5.4 billion, increasing its bitcoin holdings by 17%.
4. Apple (Nasdaq: AAPL)
Apple gained mildly by 0.94%, with the trading volume of 10.76B. Apple proposed investing $100 million in Indonesia for a component factory; potential OLED upgrades for MacBook Pro; Tim Cook visits China focusing on supply chain; Apple partners unveiled at China showcase; Mercedes collaborates with Apple Watch for enhanced car integration.
5. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 2.20%, with the trading volume of 9.82B. Microsoft is closing the Xbox avatar editor due to low engagement and has announced a new AI tool, Semantic Kernel, with OpenAPI extension support for .NET and Python. Additionally, Microsoft 365 services faced a major outage affecting Outlook, Teams, and others.
6. Amazon (Nasdaq: AMZN)
Amazon.Com gained solidly by 3.18%, with the trading volume of 8.56B. Amazon plans to invest $8 billion over two years in Anthropic models, expanding its relationship with Philips to enhance HealthSuite services. IBM Granite 3.0 AI will integrate with AWS. Amazon faces a Japanese antitrust probe over alleged seller coercion.
7. Meta Platforms (Nasdaq: META)
Meta Platforms gained mildly by 1.49%, with the trading volume of 5.92B. Meta's social platform Threads gained over 35 million new users in November, maintaining daily sign-ups above one million for three consecutive months. The company will face an FTC antitrust trial in April 2025, and a class action lawsuit related to the Cambridge Analytica scandal proceeds.
8. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany gained solidly by 4.55%, with the trading volume of 5.23B. Eli Lilly's new weight-loss drug may soon be covered by U.S. Medicare and Medicaid, reducing out-of-pocket costs by up to 95% for millions. Eli Lilly has also applied for a new indication for their drug in China, expanding its presence in the market.
9. Amgen (Nasdaq: AMGN)
Amgen dropped solidly by -4.76%, with the trading volume of 4.56B. Amgen's obesity drug MariTide, administered monthly, showed up to 20% weight loss in non-diabetics, matching Eli Lilly's Zepbound results but with greater side effects. Wall Street was dissatisfied with the trial data.
10. Advanced Micro Devices (Nasdaq: AMD)
Advanced Micro Devices dipped mildly by -2.42%, with the trading volume of 4.41B. AMD released ROCm 6.3, integrating SGLang for AI acceleration and redesigned FlashAtten, also reportedly aims to enter the smartphone chip market using TSMC's 3nm process to expand its presence in the mobile device industry.
Nvidia gained mildly by 0.66%, with the trading volume of 25.84B. NVIDIA is set to release the new RTX 5090D graphics card, which will likely have reduced specifications but align closely with the RTX 5090 in hardware and performance.
2. Tesla (Nasdaq: TSLA)
Tesla dipped mildly by -0.11%, with the trading volume of 20.95B. Tesla's Texas plant may discharge toxic wastewater; UBS warns Tesla's valuation is driven by market sentiment, not fundamentals; Tesla cuts Model Y price by $10,000; Tesla recruits AI remote operation team; California's EV subsidies may exclude Tesla.
3. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated plunged by -12.33%, with the trading volume of 17.50B. MicroStrategy disclosed five insider transactions on November 25 and recently acquired approximately 55,500 bitcoins for about $5.4 billion, increasing its bitcoin holdings by 17%.
4. Apple (Nasdaq: AAPL)
Apple gained mildly by 0.94%, with the trading volume of 10.76B. Apple proposed investing $100 million in Indonesia for a component factory; potential OLED upgrades for MacBook Pro; Tim Cook visits China focusing on supply chain; Apple partners unveiled at China showcase; Mercedes collaborates with Apple Watch for enhanced car integration.
5. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 2.20%, with the trading volume of 9.82B. Microsoft is closing the Xbox avatar editor due to low engagement and has announced a new AI tool, Semantic Kernel, with OpenAPI extension support for .NET and Python. Additionally, Microsoft 365 services faced a major outage affecting Outlook, Teams, and others.
6. Amazon (Nasdaq: AMZN)
Amazon.Com gained solidly by 3.18%, with the trading volume of 8.56B. Amazon plans to invest $8 billion over two years in Anthropic models, expanding its relationship with Philips to enhance HealthSuite services. IBM Granite 3.0 AI will integrate with AWS. Amazon faces a Japanese antitrust probe over alleged seller coercion.
7. Meta Platforms (Nasdaq: META)
Meta Platforms gained mildly by 1.49%, with the trading volume of 5.92B. Meta's social platform Threads gained over 35 million new users in November, maintaining daily sign-ups above one million for three consecutive months. The company will face an FTC antitrust trial in April 2025, and a class action lawsuit related to the Cambridge Analytica scandal proceeds.
8. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany gained solidly by 4.55%, with the trading volume of 5.23B. Eli Lilly's new weight-loss drug may soon be covered by U.S. Medicare and Medicaid, reducing out-of-pocket costs by up to 95% for millions. Eli Lilly has also applied for a new indication for their drug in China, expanding its presence in the market.
9. Amgen (Nasdaq: AMGN)
Amgen dropped solidly by -4.76%, with the trading volume of 4.56B. Amgen's obesity drug MariTide, administered monthly, showed up to 20% weight loss in non-diabetics, matching Eli Lilly's Zepbound results but with greater side effects. Wall Street was dissatisfied with the trial data.
10. Advanced Micro Devices (Nasdaq: AMD)
Advanced Micro Devices dipped mildly by -2.42%, with the trading volume of 4.41B. AMD released ROCm 6.3, integrating SGLang for AI acceleration and redesigned FlashAtten, also reportedly aims to enter the smartphone chip market using TSMC's 3nm process to expand its presence in the mobile device industry.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.